世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

欧州副鼻腔組織切除の市場規模、シェア&トレンド分析レポート:製品別(内視鏡、篩骨鉗子、鼻用ハサミ、キュレット)、エンドユーザー別、国別、セグメント別予測、2022年~2030年


Europe Sinus Tissue Resection Market Size, Share & Trends Analysis Report By Product (Endoscopes, Ethmoid Forceps, Nasal Scissors, Curetts), By End-use, By Country, And Segment Forecasts, 2022 - 2030

欧州副鼻腔組織切除術の市場成長・トレンド グランドビューリサーチ社の最新レポートによると、欧州の副鼻腔組織切除の市場規模は2030年までに2億6360万米ドルに達すると予測されています。2022年から2030年ま... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2022年7月25日 US$3,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
86 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

欧州副鼻腔組織切除術の市場成長・トレンド

グランドビューリサーチ社の最新レポートによると、欧州の副鼻腔組織切除の市場規模は2030年までに2億6360万米ドルに達すると予測されています。2022年から2030年までCAGR6.2%で拡大すると予測されています。慢性副鼻腔炎の有病率の上昇、低侵襲手術への嗜好の高まり、技術の進歩が、予測期間中の業界の成長を促進すると予想されます。副鼻腔組織切除用製品の売上は大幅に減少しましたが、予測期間中に回復・拡大するものと思われます。閉鎖や規制により、選択的手術の数が減少し、副鼻腔組織切除術製品の売上がさらに減少しました。

ヨーロッパのほとんどの国では、パンデミックによって大きな人命損失と経済的損失が発生しました。イタリアのように老齢人口が多い国は、ウイルスの影響を大きく受け、そこから回復するのは困難な状況でした。しかし、欧州各国は以前にも増して医療体制に力を入れており、近い将来、同じような状況に陥らないよう、最善を尽くしている。しかし、集団予防接種の実施や経済開放、経済活動の再開に伴い、市場はすでに回復に転じています。

また、慢性副鼻腔炎が増加していることも、本市場の成長を後押しする要因の一つです。国立医療技術評価機構(National Institute for Health and Care Excellence)によると、慢性副鼻腔炎はヨーロッパで一般的な疾患であり、英国では成人の10人に1人が罹患していると言われています。また、European Forum for Research and Foundation in Allergy and Airway Diseasesによると、ヨーロッパ地域全体で人口の約10%が慢性鼻炎に悩まされています。

欧州副鼻腔組織切除術市場レポートハイライト

- 製品別では、使用量の増加と高価格帯により、内視鏡セグメントが2021年に最大の収益シェアを占めた

- エンドユーザー別では、患者の大半が病院で手術を受けることを選択していることから、病院セグメントが2021年に最大の売上高シェアを占めた

- アレルギー性鼻炎の有病率の増加と医療制度の確立により、ドイツが2021年に最大の売上高シェアを占めた

- パンデミックにより、患者の病院受診が減少し、政府による規制により選択的手術の件数が減少したため、市場はマイナスの影響を受けました。



ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End-use
1.1.3. Country scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in Europe
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.2.3. Country outlook
2.3. Competitive Insights
Chapter 3. Europe Sinus Tissue Resection Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic sinusitis
3.4.1.2. Rising preference for minimally invasive surgeries
3.4.1.3. Technological advancements
3.4.2. Market restraint analysis
3.4.2.1. Lack of awareness and limited healthcare spending in developing countries
3.5. Europe Sinus Tissue Resection Surgery Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Europe Sinus Tissue Resection Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Endoscopes
4.1.2. Ethmoid Forceps
4.1.3. Nasal Scissors
4.1.4. Curetts
4.1.5. Others
4.2. Product Market Share, 2021 & 2030
4.3. Segment Dashboard
4.4. Europe Sinus Tissue Resection Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.5.1. Endoscopes
4.5.1.1. Market estimates and forecast, 2017 to 2030 (USD Million)
4.5.2. Ethmoid Forceps
4.5.2.1. Market estimates and forecast, 2017 to 2030 (USD Million)
4.5.3. Nasal Scissors
4.5.3.1. Market estimates and forecast, 2017 to 2030 (USD Million)
4.5.4. Curetts
4.5.4.1. Market estimates and forecast, 2017 to 2030 (USD Million)
4.5.5. Others
4.5.5.1. Market estimates and forecast, 2017 to 2030 (USD Million)
Chapter 5. Europe Sinus Tissue Resection Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Ambulatory Surgical Centers
5.1.3. Clinics
5.1.4. Others
5.2. End-use Market Share, 2021 & 2030
5.3. Segment Dashboard
5.4. Europe Sinus Tissue Resection Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Market estimates and forecast, 2017 to 2030 (USD Million)
5.5.2. Ambulatory Surgical Centers
5.5.2.1. Market estimates and forecast, 2017 to 2030 (USD Million)
5.5.3. Clinics
5.5.3.1. Market estimates and forecast, 2017 to 2030 (USD Million)
5.5.4. Others
5.5.4.1. Market estimates and forecast, 2017 to 2030 (USD Million)
Chapter 6. Europe Sinus Tissue Resection Market: Country Estimates & Trend Analysis
6.1. Country market share analysis, 2021 & 2030
6.2. Country Market Dashboard
6.3. Europe Country Market Snapshot
6.4. Country Market Share and Leading Players, 2021
6.4.1. U.K.
6.4.2. Germany
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.4.6. Switzerland
6.4.7. Israel
6.4.8. Sweden
6.4.9. Norway
6.4.10. Greece
6.4.11. Austria
6.4.12. The Netherlands
6.4.13. Portugal
6.4.14. Luxembourg
6.4.15. Denmark
6.4.16. Iceland
6.4.17. Ireland
6.4.18. Belgium
6.4.19. Finland
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1. U.K.
6.5.2. Germany
6.5.3. France
6.5.4. Italy
6.5.5. Spain
6.5.6. Switzerland
6.5.7. Israel
6.5.8. Sweden
6.5.9. Norway
6.5.10. Greece
6.5.11. Austria
6.5.12. The Netherlands
6.5.13. Portugal
6.5.14. Luxembourg
6.5.15. Denmark
6.5.16. Iceland
6.5.17. Ireland
6.5.18. Belgium
6.5.19. Finland
6.6. Europe
6.6.1. U.K.
6.6.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.2. Germany
6.6.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.3. France
6.6.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.4. Italy
6.6.4.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.5. Spain
6.6.5.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.6. Switzerland
6.6.6.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.7. Israel
6.6.7.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.8. Sweden
6.6.8.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.9. Norway
6.6.9.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.10. Greece
6.6.10.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.11. Brazil
6.6.11.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.12. Austria
6.6.12.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.13. Netherlands
6.6.13.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.14. Portugal
6.6.14.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.15. Luxembourg
6.6.15.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.16. Denmark
6.6.16.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.17. Iceland
6.6.17.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.18. Ireland
6.6.18.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.19. Belgium
6.6.19.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.20. Finland
6.6.20.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Medtronic, plc.
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2021
7.3.4. Entellus Medical, Inc.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Integra Lifesciences
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. B. Braun Melsungen AG
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Bausch & Lomb Incorporated
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Karl Storz & Co. Kg
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives

 

ページTOPに戻る


 

Summary

Europe Sinus Tissue Resection Market Growth & Trends

The Europe sinus tissue resection market size is expected to reach USD 263.6 million by 2030, based on a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.2% from 2022 to 2030. The rise in the prevalence of chronic sinusitis, rising preference for minimally invasive surgeries, and technological advancements are expected to propel the growth of the industry over the forecast period. Although the market witnessed a significant fall in the sales of sinus tissue resection products, It is expected to recover and flourish over the forecast period. The lockdowns and restrictions resulted in a reduced number of elective surgeries, which further led to a fall in the sales of sinus tissue resection products.

Most countries in Europe specifically observed a major loss of life and financial losses due to the pandemic. Countries like Italy, which had a huge geriatric population, were badly hit by the virus, and recovering from it has been difficult. However, with the European countries now focusing on their healthcare systems more than ever before, the region is trying its best to combat similar situations in the near future. However, with the conduction of mass vaccination programs, the opening of the economies, and economic activities resuming, the market has already started to recover.

Increasing prevalence of chronic sinusitis is among the major factors anticipated to positively contribute to the industry growth. As per the National Institute for Health and Care Excellence, chronic sinusitis is a common condition in Europe, and affects 1 in 10 adults in the U.K. adults. Additionally, according to the European Forum for Research and Foundation in Allergy and Airway Diseases, around 10% of the population is suffering from chronic rhinitis across the European region.

Europe Sinus Tissue Resection Market Report Highlights

• Based on product, the endoscopes segment held the largest revenue share in 2021 owing to its increased usage and higher price range

• On the basis of end-use, the hospitals segment held the largest revenue share in 2021 due to the majority of patients opting to undergo surgeries in the hospital setting

• Germany held the largest revenue share in 2021 owing to an increase in the prevalence of allergic rhinitis and a well-established healthcare system

• The market observed a negative impact due to the pandemic as a result of reduced hospital visits by the patients and restrictions led by the government that led to a fall in the number of elective surgeries



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End-use
1.1.3. Country scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in Europe
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.2.3. Country outlook
2.3. Competitive Insights
Chapter 3. Europe Sinus Tissue Resection Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic sinusitis
3.4.1.2. Rising preference for minimally invasive surgeries
3.4.1.3. Technological advancements
3.4.2. Market restraint analysis
3.4.2.1. Lack of awareness and limited healthcare spending in developing countries
3.5. Europe Sinus Tissue Resection Surgery Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Europe Sinus Tissue Resection Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Endoscopes
4.1.2. Ethmoid Forceps
4.1.3. Nasal Scissors
4.1.4. Curetts
4.1.5. Others
4.2. Product Market Share, 2021 & 2030
4.3. Segment Dashboard
4.4. Europe Sinus Tissue Resection Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.5.1. Endoscopes
4.5.1.1. Market estimates and forecast, 2017 to 2030 (USD Million)
4.5.2. Ethmoid Forceps
4.5.2.1. Market estimates and forecast, 2017 to 2030 (USD Million)
4.5.3. Nasal Scissors
4.5.3.1. Market estimates and forecast, 2017 to 2030 (USD Million)
4.5.4. Curetts
4.5.4.1. Market estimates and forecast, 2017 to 2030 (USD Million)
4.5.5. Others
4.5.5.1. Market estimates and forecast, 2017 to 2030 (USD Million)
Chapter 5. Europe Sinus Tissue Resection Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Ambulatory Surgical Centers
5.1.3. Clinics
5.1.4. Others
5.2. End-use Market Share, 2021 & 2030
5.3. Segment Dashboard
5.4. Europe Sinus Tissue Resection Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Market estimates and forecast, 2017 to 2030 (USD Million)
5.5.2. Ambulatory Surgical Centers
5.5.2.1. Market estimates and forecast, 2017 to 2030 (USD Million)
5.5.3. Clinics
5.5.3.1. Market estimates and forecast, 2017 to 2030 (USD Million)
5.5.4. Others
5.5.4.1. Market estimates and forecast, 2017 to 2030 (USD Million)
Chapter 6. Europe Sinus Tissue Resection Market: Country Estimates & Trend Analysis
6.1. Country market share analysis, 2021 & 2030
6.2. Country Market Dashboard
6.3. Europe Country Market Snapshot
6.4. Country Market Share and Leading Players, 2021
6.4.1. U.K.
6.4.2. Germany
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.4.6. Switzerland
6.4.7. Israel
6.4.8. Sweden
6.4.9. Norway
6.4.10. Greece
6.4.11. Austria
6.4.12. The Netherlands
6.4.13. Portugal
6.4.14. Luxembourg
6.4.15. Denmark
6.4.16. Iceland
6.4.17. Ireland
6.4.18. Belgium
6.4.19. Finland
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1. U.K.
6.5.2. Germany
6.5.3. France
6.5.4. Italy
6.5.5. Spain
6.5.6. Switzerland
6.5.7. Israel
6.5.8. Sweden
6.5.9. Norway
6.5.10. Greece
6.5.11. Austria
6.5.12. The Netherlands
6.5.13. Portugal
6.5.14. Luxembourg
6.5.15. Denmark
6.5.16. Iceland
6.5.17. Ireland
6.5.18. Belgium
6.5.19. Finland
6.6. Europe
6.6.1. U.K.
6.6.1.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.2. Germany
6.6.2.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.3. France
6.6.3.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.4. Italy
6.6.4.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.5. Spain
6.6.5.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.6. Switzerland
6.6.6.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.7. Israel
6.6.7.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.8. Sweden
6.6.8.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.9. Norway
6.6.9.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.10. Greece
6.6.10.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.11. Brazil
6.6.11.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.12. Austria
6.6.12.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.13. Netherlands
6.6.13.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.14. Portugal
6.6.14.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.15. Luxembourg
6.6.15.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.16. Denmark
6.6.16.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.17. Iceland
6.6.17.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.18. Ireland
6.6.18.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.19. Belgium
6.6.19.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
6.6.20. Finland
6.6.20.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Medtronic, plc.
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2021
7.3.4. Entellus Medical, Inc.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Integra Lifesciences
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. B. Braun Melsungen AG
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Bausch & Lomb Incorporated
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Karl Storz & Co. Kg
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(一般医療機器)の最新刊レポート

Grand View Research社の一般医療機器分野での最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る